A plain-language guide to care in the US
GHK-Cu consultation: first, make sense of it.
Find out whether an offer is for a cream or a shot. Check what the research says and prepare questions for a visit.
GHK-Cu notes · September 30, 2026
A name is a starting point, not an answer
| Starting point | What it tells you | What is still a question |
|---|---|---|
| The ingredient | GHK-Cu is copper bound to a peptide: a short chain made from the blocks that form proteins. | Will it go on the skin or be given as a shot? |
| The skin-care name | A skin-care label may call it copper tripeptide-1. | What does this product claim to do? |
| The research | There are few studies in people, and most are about skin creams. | Did the study test a cream or a shot for the problem I want help with? |
Is it a real, approved treatment?
GHK-Cu is a real ingredient. That does not mean a medicine containing it has approval.
The Food and Drug Administration (FDA), which oversees US drugs, has approved no medicine containing GHK-Cu as of September 30, 2026.
On September 30, 2026, the FDA treats GHK-Cu shots separately from GHK-Cu used without shots.
Ask whether the offer is a skin product or a shot. Then ask what studies support it, who makes it and what the whole visit would cost.